Mid-Trimester Amniocentesis Fetal Loss Rate

Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of obstetrics and gynaecology Canada 2007-07, Vol.29 (7), p.586-590
Hauptverfasser:	Wilson, R. Douglas, MD, FRCSC, Langlois, Sylvie, MD, FRCPC, Johnson, Jo-Ann, MD, FRCSC, Wilson, R. Douglas, MD, Desilets, Valerie, MD, Audibert, François, MD, Gagnon, Alain, MD, Johnson, Jo-Ann, MD, Wyatt, Philip, MD, PhD, Allen, Victoria, MD, Langlois, Sylvie, MD, Blight, Claire, RN, Chitayat, David, MD, Farrell, Sandra A., MD, Nelson, Tanya, PhD, Nikkel, Sarah M., MD, Skidmore, David, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Amniocentesis - adverse effects Female Fetal Death - epidemiology Fetal Death - etiology genetic amniocentesis Humans miscarriage Obstetrics and Gynecology Pregnancy Pregnancy Trimester, Second prenatal screening
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Objective To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome Reduction of benign biopsy rates. Benefits To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement The risk of postprocedure loss is unique to the individual and is based on multiple variables.
ISSN:	1701-2163
DOI:	10.1016/S1701-2163(16)32501-4